Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Saturday, December 3, 2022
Compounding Pharmacies: "Novo Nordisk A/S, the maker of Ozempic, said it doesn’t supply ingredients to compounders and issued a warning earlier this year about compounded semaglutide. The Danish pharmaceutical giant holds the patent on semaglutide, making it difficult for others to precisely replicate the drug, and it is suing several companies for patent infringement. Some compounders are mixing the drug with supplements, according to providers prescribing them to patients. Already, several recalls have been reported to the FDA".